Oncodesign Announces Publication of an Abstract for the 54th ASCO Annual Meeting in Chicago | Business Wire

Oncodesign Announces Publication of an Abstract for the 54th ASCO Annual Meeting in Chicago | Business Wire: Regulatory News: ONCODESIGN (Paris:ALONC) (ALONC – FR0011766229), a biopharmaceutical company specializing in precision medicine, announces the public